Related Experiment Videos
Resource requirements for transgenic livestock research
1Animal Reproduction and Biotechnology Laboratory, Colorado State University, Fort Collins 80523.
Journal of Animal Science
|January 1, 1993
Summary
Producing transgenic animals is costly and time-consuming, requiring extensive characterization of each line. Significant variation exists between lines, necessitating thorough evaluation for safety and efficacy, especially in livestock.
Area of Science:
- Animal Biotechnology
- Genetics
- Reproductive Physiology
Background:
- Transgenic research involves low-efficiency steps, demanding substantial investment to generate and characterize founder animals.
- Significant phenotypic variation occurs among transgenic lines derived from the same DNA construct.
- Livestock species require extensive embryo manipulation and recipient pregnancies for single founder production.
Purpose of the Study:
- To outline the challenges and requirements for producing and characterizing transgenic animal lines.
- To highlight the cost, time, and expertise involved in transgenic research, particularly for agricultural applications.
Main Methods:
- DNA injection into embryos followed by transfer to recipient animals.
- Polymerase chain reaction (PCR) screening of embryo biopsies to reduce costs.
- Comprehensive characterization of transgenic lines, including phenotype, safety, and efficacy in both sexes and different genetic states (hemizygous/homozygous).
Main Results:
- Generating a single transgenic founder animal is labor-intensive, requiring hundreds of embryos.
- Characterizing transgenic lines is a significant logistical challenge, often exceeding the effort of founder production.
- Long generation intervals in some species, like livestock, extend characterization timelines considerably.
Conclusions:
- Successful transgenic projects require expertise in molecular biology, embryo manipulation, reproductive physiology, and specific biological systems.
- Characterization demands for agricultural production are higher than for research purposes due to safety and efficacy concerns.
- Cost reduction strategies, such as embryo screening, are employed, but the overall process remains resource-intensive.